×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Nipun Mehta
Nipun Mehta
Crack The Code: Aims to educate investors
Mkt consolidating, may see 3-5% upside/downside: Nipun Mehta
Upward momentum for mkt to continue; like autos, IT: Nipun Mehta
Mkt consolidation a positive but headwinds continue: Blue Ocean
What next if Fed hikes rates tomorrow?
Use mkt fall to buy stks; like banking, IT, pharma: Experts
Returns could take longer but buy on dips, says Nipun Mehta
Nifty to rally further; hold on to IT, pharma: Experts
Nippon Life hiking stake in Rel Cap: Should we invest now?
Avoid betting on Bank Nifty now; go for defensives: Sukhani
Will you buy Ranbaxy amid uncertainty over 2 key generics?
Is Sun Pharma expensive at current valuations?
Nifty to see big bouts of resistance soon: Experts
Sun Pharma a must in core portfolio: Experts
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio